ARCHIVES

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

One Flexible Sigmoidoscopy Can Reduce Risk by 31 Percent

September 30, 2011

NCI Resumes Clinical Education Grants

March 18, 1983

No Cancer Letter For Two Weeks

August 10, 1990

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

ASCO Foundation Raised $200,000 In Its First Year.

June 2, 2000